Health TrialsbyHealthPanel

Anti-mullerian Hormone Levels in Healthy Females

ConditionHealthy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
AgeUp to 18
SponsorErin Rowell

About this trial

The purpose of this study is to have a better understanding of the normal blood levels of AMH in females from 0-18 years of age and how the blood AMH levels correspond to a female's reproductive development.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Pre- and post-pubertal females

Ages 0-18 years old

Tanner Stage I- V

Undergoing routine outpatient surgical procedure

Disqualifiers

Previous diagnosis of an illness associated with premature ovarian failure (Turner's syndrome, Fragile X permutation carrier) or endocrine disorder associated with irregular menstrual cycles (Cushing's disease, poorly-controlled Thyroid disease, hyperprolactinemia, polycystic ovary syndrome, and congenital adrenal hyperplasia) or insulin-dependent diabetes mellitus or autoimmune disorders

Previous diagnosis of any malignancy or any history of systemic/local chemotherapy, radiation therapy, or stem-cell transplant.

Previous surgical excision of one ovary or both ovaries

Pregnant females

Trial design

Design model

Single group

Treatments tested in this trial

  • Blood sample collection

    Diagnostic test

    Blood samples are collected for diagnostically assessing how the blood AMH levels correspond to a female's reproductive development

Treatment groups

100 Participants
are divided into 1 treatment group
Group A: Blood sample collectionOther 1 intervention

Trial outcomes

Primary outcomes

1

Anti-mullerian Hormone Levels in Healthy Females

The primary outcome measure is to get a better understanding of the normal AMH levels in children (girls aged 0-18 years) in order to better assess a girl's risk of not being able to have children if she is a cancer patient, and in offering her and her family options to increase the chances of having her own children

Time frame
3 Years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Erin Rowell

Lead sponsor

Ann & Robert H Lurie Children's Hospital of Chicago

Sponsor institution

Ann & Robert H Lurie Children's Hospital of Chicago

Collaborator

Source ClinicalTrials.gov
Apply now